[{"address1": "601 Brickell Key Drive", "address2": "Suite 1000", "city": "Miami", "state": "FL", "zip": "33131", "country": "United States", "phone": "305 203 2034", "website": "https://www.smmttx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis, as well as in Phase III clinical trials for the treatment of non-small lung cancer. The company was founded in 2003 and is headquartered in Miami, Florida.", "fullTimeEmployees": 159, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert W. Duggan", "age": 80, "title": "Co-CEO & Executive Chairman", "yearBorn": 1944, "fiscalYear": 2024, "totalPay": 158613, "exercisedValue": 0, "unexercisedValue": 1133457}, {"maxAge": 1, "name": "Dr. Mahkam  Zanganeh D.D.S., M.B.A.", "age": 54, "title": "Co-CEO, President & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 1161021, "exercisedValue": 0, "unexercisedValue": 128563160}, {"maxAge": 1, "name": "Mr. Manmeet Singh Soni CPA", "age": 46, "title": "COO, CFO & Director", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 1261021, "exercisedValue": 0, "unexercisedValue": 107858016}, {"maxAge": 1, "name": "Prof. Dame Kay Davies DBE, FRS CBE", "age": 73, "title": "Co-Founder, Chairman of Scientific Advisory Board and Scientific Advisor", "yearBorn": 1951, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bhaskar  Anand", "age": 47, "title": "Chief Accounting Officer", "yearBorn": 1977, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nathan  LiaBraaten", "title": "Senior Director of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dave  Gancarz", "title": "Chief Business & Strategy Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Fong  Clow", "title": "Chief Biometrics Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Urte  Gayko Ph.D.", "age": 53, "title": "Chief Regulatory, Quality & Pharmacovigilance Officer", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Allen S. Yang M.D., Ph.D.", "age": 56, "title": "Head of R&D Strategy", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 10, "compensationRisk": 10, "shareHolderRightsRisk": 5, "overallRisk": 10, "governanceEpochDate": 1764547200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 18.81, "open": 18.88, "dayLow": 18.1, "dayHigh": 19.1, "regularMarketPreviousClose": 18.81, "regularMarketOpen": 18.88, "regularMarketDayLow": 18.1, "regularMarketDayHigh": 19.1, "payoutRatio": 0.0, "beta": -1.531, "forwardPE": -48.184208, "volume": 2434033, "regularMarketVolume": 2434033, "averageVolume": 3867812, "averageVolume10days": 2479020, "averageDailyVolume10Day": 2479020, "bid": 17.38, "ask": 19.76, "bidSize": 2, "askSize": 2, "marketCap": 13630742528, "fiftyTwoWeekLow": 15.55, "fiftyTwoWeekHigh": 36.91, "allTimeHigh": 36.91, "allTimeLow": 0.66, "fiftyDayAverage": 19.3125, "twoHundredDayAverage": 21.982275, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 13397616640, "profitMargins": 0.0, "floatShares": 124783458, "sharesOutstanding": 744442538, "sharesShort": 31236590, "sharesShortPriorMonth": 32272331, "sharesShortPreviousMonthDate": 1760486400, "dateShortInterest": 1763078400, "sharesPercentSharesOut": 0.042, "heldPercentInsiders": 0.86053, "heldPercentInstitutions": 0.1441, "shortRatio": 9.18, "shortPercentOfFloat": 0.2638, "impliedSharesOutstanding": 744442538, "bookValue": 0.258, "priceToBook": 70.968994, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -921617024, "trailingEps": -1.25, "forwardEps": -0.38, "enterpriseToEbitda": -14.329, "52WeekChange": -0.018756688, "SandP52WeekChange": 0.13506866, "quoteType": "EQUITY", "currentPrice": 18.31, "targetHighPrice": 42.523693, "targetLowPrice": 12.083927, "targetMeanPrice": 32.33647, "targetMedianPrice": 35.435966, "recommendationMean": 1.6875, "recommendationKey": "buy", "numberOfAnalystOpinions": 13, "totalCash": 238554000, "totalCashPerShare": 0.32, "ebitda": -934987008, "totalDebt": 5428000, "quickRatio": 3.674, "currentRatio": 3.796, "debtToEquity": 2.823, "returnOnAssets": -1.5288, "returnOnEquity": -2.92492, "freeCashflow": 73795752, "operatingCashflow": -269664992, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SMMT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1425565800000, "postMarketChangePercent": 0.00055209984, "postMarketPrice": 18.3101, "postMarketChange": 0.00010108948, "regularMarketChange": -0.5, "regularMarketDayRange": "18.1 - 19.1", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 3867812, "fiftyTwoWeekLowChange": 2.7599993, "fiftyTwoWeekLowChangePercent": 0.17749192, "fiftyTwoWeekRange": "15.55 - 36.91", "fiftyTwoWeekHighChange": -18.6, "fiftyTwoWeekHighChangePercent": -0.5039285, "fiftyTwoWeekChangePercent": -1.8756688, "earningsTimestamp": 1760963400, "earningsTimestampStart": 1760963400, "earningsTimestampEnd": 1760963400, "earningsCallTimestampStart": 1746131400, "earningsCallTimestampEnd": 1746131400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.25, "epsForward": -0.38, "epsCurrentYear": -0.76733, "priceEpsCurrentYear": -23.861963, "corporateActions": [], "postMarketTime": 1764981402, "regularMarketTime": 1764968400, "exchange": "NGM", "messageBoardId": "finmb_11611587", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "shortName": "Summit Therapeutics Inc.", "longName": "Summit Therapeutics Inc.", "fiftyDayAverageChange": -1.0025005, "fiftyDayAverageChangePercent": -0.051909413, "twoHundredDayAverageChange": -3.6722755, "twoHundredDayAverageChangePercent": -0.1670562, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Summit Therapeutics plc", "nameChangeDate": "2025-12-05", "averageAnalystRating": "1.7 - Buy", "cryptoTradeable": false, "regularMarketChangePercent": -2.65816, "regularMarketPrice": 18.31, "displayName": "Summit Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-12-06"}]